Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms.
Adolescent
Adult
Ataxia Telangiectasia
/ diagnosis
Ataxia Telangiectasia Mutated Proteins
/ genetics
Child
Child, Preschool
Cross-Sectional Studies
Delayed Diagnosis
Diagnosis, Differential
Female
Genetic Testing
/ methods
Genotype
Humans
Male
Movement Disorders
/ diagnosis
Mutation
Neurodegenerative Diseases
/ diagnosis
Phenotype
Retrospective Studies
Young Adult
ATM kinase activity
ataxia telangiectasia
cerebellar ataxia
immunodeficiency
movement disorder
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
10
2021
accepted:
07
01
2022
entrez:
14
2
2022
pubmed:
15
2
2022
medline:
16
3
2022
Statut:
epublish
Résumé
Ataxia-telangiectasia (A-T) is a neurodegenerative and primary immunodeficiency disorder (PID) characterized by cerebellar ataxia, oculocutaneous telangiectasia, immunodeficiency, progressive respiratory failure, and an increased risk of malignancies. It demands specialized care tailored to the individual patient's needs. Besides the classical ataxia-telangiectasia (classical A-T) phenotype, a variant phenotype (variant A-T) exists with partly overlapping but some distinctive disease characteristics. Here we present a case series of 6 patients with classical A-T and variant A-T, which illustrates the phenotypic variability of A-T that can present in childhood with prominent extrapyramidal features, with or without cerebellar ataxia. We report the clinical data, together with a detailed genotype description, immunological analyses, and related expression of the ATM protein. We show that the presence of some residual ATM kinase activity leads to the clinical phenotype variant A-T that differs from the classical A-T. Our data illustrate that the diagnosis of the variant form of A-T can be delayed and difficult, while early recognition of the variant form as well as the classical A-T is a prerequisite for providing a correct prognosis and appropriate rehabilitation and support, including the avoidance of diagnostic X-ray procedures, given the increased risk of malignancies and the higher risk for side effects of subsequent cancer treatment.
Identifiants
pubmed: 35154108
doi: 10.3389/fimmu.2022.791522
pmc: PMC8831727
doi:
Substances chimiques
ATM protein, human
EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins
EC 2.7.11.1
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
791522Informations de copyright
Copyright © 2022 Blanchard-Rohner, Peirolo, Coulon, Korff, Horvath, Burkhard, Gumy-Pause, Ranza, Jandus, Dibra, Taylor and Fluss.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pract Neurol. 2020 Oct;20(5):404-414
pubmed: 32958592
J Allergy Clin Immunol. 2013 May;131(5):1367-75.e9
pubmed: 23566627
Mov Disord. 2018 Aug;33(8):1238-1247
pubmed: 29436738
Clin Exp Immunol. 2014 May;176(2):275-82
pubmed: 24387201
Orphanet J Rare Dis. 2016 Nov 25;11(1):159
pubmed: 27884168
Pediatr Allergy Immunol. 2019 May;30(3):277-288
pubmed: 30685876
Handb Clin Neurol. 2015;132:199-214
pubmed: 26564081
Am J Med Genet A. 2020 Dec;182(12):2971-2975
pubmed: 32918381
DNA Repair (Amst). 2013 Aug;12(8):600-4
pubmed: 23680599
Mov Disord. 2021 Feb;36(2):283-297
pubmed: 33022077
J Pediatr. 1997 Mar;130(3):388-93
pubmed: 9063413
Nat Rev Dis Primers. 2019 Sep 19;5(1):64
pubmed: 31537806
J Multidiscip Healthc. 2021 Jun 28;14:1637-1644
pubmed: 34234451
Ann Neurol. 2019 Feb;85(2):170-180
pubmed: 30549301
Hum Mutat. 2012 Mar;33(3):561-71
pubmed: 22213089
J Pediatr. 2004 Apr;144(4):505-11
pubmed: 15069401
Clin Exp Immunol. 2008 Aug;153(2):214-20
pubmed: 18505428
J Allergy Clin Immunol. 2011 Aug;128(2):382-9.e1
pubmed: 21665257
J Pediatr. 2011 Sep;159(3):466-471.e1
pubmed: 21429505
Am J Ophthalmol. 2002 Dec;134(6):891-6
pubmed: 12470759
Dev Med Child Neurol. 2017 Jul;59(7):680-689
pubmed: 28318010
Neurology. 2009 Aug 11;73(6):430-7
pubmed: 19535770